Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999US5888726 Pertussis toxin induced lymphocytosis
03/30/1999US5888553 Non-steroidal anabolic composition
03/30/1999US5888552 Anti-cancer therapeutic compositions containing whey protein concentrate
03/30/1999US5888529 After surgery
03/30/1999US5888522 Tissue protective and regenerative compositions
03/30/1999US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae
03/30/1999US5888516 Genetic engineered protein
03/30/1999US5888514 Natural composition for treating bone or joint inflammation
03/30/1999US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host
03/30/1999US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity
03/30/1999US5888511 Treatment of autoimmune diseases, including AIDS
03/30/1999US5888510 Administering antibody
03/30/1999US5888509 Administering antibody
03/30/1999US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore
03/30/1999US5888507 Treatment for insulin dependent diabetes
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888505 Mixing with halide compound
03/30/1999US5888502 Recombinant retroviruses
03/30/1999US5888498 Cellular and animal models for diseases associated with mitochondrial defects
03/30/1999US5888495 Combining macrophage colony stimulating factor, nonionic surfactant, glycine, sucrose, buffer in liquid solution, lyophilizing
03/30/1999US5888493 Ophthalmic aqueous gel formulation and related methods
03/30/1999US5888477 Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
03/30/1999US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/30/1999CA2093133C Synthetic lung surfactant
03/30/1999CA2085975C Dentinal desensitizing compositions
03/30/1999CA1340475C Dopamine analog amide
03/30/1999CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna
03/30/1999CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein
03/26/1999CA2248390A1 Complex of human growth hormone and zinc and use
03/25/1999WO1999014357A2 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
03/25/1999WO1999014353A2 Intrabody-mediated control of immune reactions
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014345A2 Medicament for treating a manifested lyme disease
03/25/1999WO1999014343A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014339A1 ASPARAGINASE PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF OBTAINABLE FROM A PARASITIC HELMINTH, IN PARTICULAR FROM $i(DIROFILARIA IMMITIS)
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014329A1 Human macrophage receptor marco
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014327A2 Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999014325A1 NOVEL Fas LIGAND DERIVATIVE
03/25/1999WO1999014324A1 Mammalian genes participating in circadian period
03/25/1999WO1999014323A1 Heregulin-gamma
03/25/1999WO1999014322A2 Allelic variant of human stat3
03/25/1999WO1999014321A1 Novel therapeutic molecules
03/25/1999WO1999014317A1 Methods for the diagnosis of feline infectious anemia
03/25/1999WO1999014312A1 Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014241A2 Compositions and methods for the treatment of immune related diseases
03/25/1999WO1999014240A1 Interleukin-17 receptor-like protein
03/25/1999WO1999014239A1 Composition for treating diabetes mellitus and obesity
03/25/1999WO1999014237A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999WO1999014236A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999014234A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014230A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999WO1999014229A1 Truncated aspartase enzyme derivatives and uses thereof
03/25/1999WO1999013914A1 Pharmaceutical compositions containing plasma protein
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013909A1 Corneal neovascularization inhibitors
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013903A1 Methods and compositions for diagnosing and treating malaria
03/25/1999WO1999013902A1 Product for promoting dural or meningeal tissue growth comprising collagen
03/25/1999WO1999013901A1 Treatment of vascular graft implants with g-csf
03/25/1999WO1999013900A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
03/25/1999WO1999013899A1 Peptides and peptidomimetics for inhibiting complement activation
03/25/1999WO1999013898A1 EC-3, AN INHIBITOR OF α4β1 AND α4β7 INTEGRINS
03/25/1999WO1999013897A1 Prevention of pregnancy miscarriages
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999013895A1 Polypeptide compositions that inhibit potassium channel activity and uses therefor
03/25/1999WO1999013894A2 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
03/25/1999WO1999013893A1 Peptide nucleic acids having antibacterial activity
03/25/1999WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999WO1999013868A1 Methods for treating ocular diseases
03/25/1999WO1999013726A1 Neuronal cells and an immunosuppressant and anti-inflammatory factor
03/25/1999WO1999004825A8 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
03/25/1999WO1999002554A3 Human herpesvirus-7 diagnostic and immunologic reagents and use thereof
03/25/1999WO1999001470A3 Peptidomimetic derivatives suicidal inhibitors of the hiv proliferation
03/25/1999WO1999001463A3 Modified glycosides, compositions comprised thereof and methods of use thereof
03/25/1999WO1999001103A3 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
03/25/1999WO1999000002A3 Cyclosporin-containing microemulsion preconcentrate composition
03/25/1999WO1998059041A3 Disease related nucleotide kinases
03/25/1999WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/25/1999WO1998056813A3 Two human membrane-fusion proteins
03/25/1999WO1998056398A3 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/25/1999WO1998055509A3 Two human dnaj-like proteins
03/25/1999WO1998055508A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/25/1999WO1998054225A3 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
03/25/1999WO1998053061A9 Three novel genes encoding a zinc finger protein, a guanine, nucleotide exchange factor and a heat shock protein or heat shock binding protein
03/25/1999WO1998052970A9 Vif-derived hiv protease inhibitors
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998051331A9 Somatostatin and somatostatin agonists for decreasing body weight
03/25/1999WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998048027A3 Materials and methods for treatment of retinal diseases
03/25/1999WO1998048011A9 Novel chimeric molecules
1 ... 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 ... 3163